Novel Triple-dose Tuberculosis Retreatment Regimen

Conditions:   Multidrug-resistant Tuberculosis;   Pulmonary Tuberculosis;   Tuberculosis;   Resistance to Tuberculostatic Drugs Interventions:   Drug: 6EH³R³Z;   Drug: 6EHRZ Sponsors:   Institute of Tropical Medicine, Belgium;   Damien Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials